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Abstract 
Background 
Discrete choice experiments (DCEs) are widely used to quantify individuals’ preferences for healthcare. 
Guidelines recommend the design of DCEs should be informed by qualitative research. However, only 
few studies go beyond guidelines by fully presenting qualitative and quantitative research jointly 
together in a mixed methods approach (MMA). 
Objectives 
Using an example study about men’s preferences for medical treatment of lower urinary tract 
symptoms (LUTS), we demonstrate how qualitative research can complement DCEs to gain a rich 
understanding of individuals’ preferences.  
Methods  
We were the first to combine online discussion groups (ODGs) with an online DCE. A thematic analysis 
of the ODGs and a conceptual map provided insights into men’s quality of life (QoL) with LUTS and 
relevant treatment attitudes. This was used to design the DCE. Men’s willingness to pay (WTP) for these 
attributes was estimated. Findings from ODGs and DCE were compared to understand WTP and 
preference heterogeneity. 
Key findings   
Men mostly valued medicine that reduced urgency and night time frequencies of urination, but avoided 
sexual side effects. We find heterogeneity in the effect of sexual side effects on men’s preferences. The 
ODGs suggest this is, because several men may be sexually inactive due to their age, being widowed or 
having comorbidities. The ODGs also raised concern about men’s awareness of LUTS.   
Conclusion 
We argue that the insights gained into men’s preferences for treatment and how LUTS affects men’s 
QoL, could not have been obtained by either the qualitative research or the DCE alone.   
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Key Points for Decision Makers  
 Guidelines recommend that DCEs should be informed by qualitative evidence. We go beyond 
these guidelines in a mixed methods approach (MMA) that treats qualitative findings and DCE 
results as being equally important. 
 In our study about men’s treatment preferences for lower urinary tract symptoms (LUTS), we 
find treatment should relieve urgency and night-time symptoms while limiting sexual side 
effects. 
 The MMA has provided a richer understanding of treatment preferences than the DCE or 
qualitative research could have provided alone. Our qualitative data was collected in online 
discussion groups, which may offer a practical alternative to face-to-face interviews, 
especially for target populations with limited mobility or sensitive research topics. 
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1 Introduction 
Discrete choice experiments (DCEs) are widely used to elicit patient and population preferences for 
healthcare [1]. DCE surveys ask respondents to choose repeatedly between mutually exclusive 
hypothetical healthcare options characterised by a set of common attributes that take different levels 
[2]. Researchers select these attributes using literature reviews, pre-defined outcome measures, 
underlying behavioural hypotheses or qualitative research [3]. Attribute selection is fundamental to 
DCEs and previous research finds that the number and type of attributes may affect the study outcome 
[4, 5]. While too many attributes may overburden respondents [6, 7], too few attributes might induce 
omitted variable bias [8, 9]. Guidelines therefore recommend to use qualitative research to identify 
and describe DCE attributes [3, 10]. This has improved the reporting of qualitative approaches in the 
DCE literature over the last years, and is increasingly considered as an important quality aspect of DCE 
studies [11]. Systematic literature reviews of health DCEs find that qualitative research has informed 
attribute selection in 54% of studies, level selection in 35% of studies and is used to test the quality of 
questionnaires [1, 12, 13]. However, few studies use qualitative research after the attribute selection 
and survey pre-testing phases of a DCE. For example, Vass et al. [11] find that only 4% of all health DCEs 
use qualitative research to collect additional evidence about individuals’ preferences or attitudes. 
There are two potential explanations for this: First, journals have tight word limits and second, 
guidelines only focus on the role of qualitative research for DCE design.  
In this paper we argue, that limiting the use of qualitative research to attribute selection does not 
uncover its full potential. Qualitative research is an established method in public health and other 
disciplines to gain insights into individuals’ health care preferences, quality of life and care context [14-
18]. Qualitative research largely focusses on uncovering heterogeneity in views, contexts and opinions. 
Hence, qualitative research has a potential to provide detailed insights into causes and types of 
preference heterogeneity that is often only accounted for in DCE analysis by allowing preferences to 
be randomly distributed in the population [19]. We aim to demonstrate how qualitative and 
quantitative methods can be analysed and reported in parallel using an example study about patients’ 
 6  
preferences for medical treatment of lower urinary tract symptoms (LUTS) associated with benign 
prostatic hyperplasia (BPH). Our mixed method approach (MMA) recognises that qualitative and 
quantitative methods are complementary and together create a detailed understanding of individuals’ 
preferences for healthcare. We are also the first to explore the use of online discussion groups (ODGs) 
as an alternative to traditional face-to-face focus groups to collect qualitative data alongside a DCE. 
ODGs can make qualitative research alongside a primarily quantitative study more practical than face-
to-face alternatives. They may also be useful to collect data from a population with limited mobility. In 
case of online DCEs, ODGs can also be used to ensure that all study participants are sampled from the 
same population. 
2 Background of the case study 
BPH is a chronic, progressive urologic condition that affects aging men and is often associated with 
LUTS [20, 21]. LUTS comprise storage symptoms (day-time urinary frequency, night-time urinary 
frequency, urgency), voiding symptoms (e.g. slow stream, splitting or spraying, hesitancy, terminal 
dribble) or post-micturition symptoms (e.g. sensation of incomplete emptying). These symptoms 
reduce men’s quality of life (QoL) and the health status of their partners [23-25].  
Several medical treatments are available for LUTS [21, 25]. These medicines have different profiles with 
regards to efficacy (e.g. reduced urge or frequency of voiding, or reduced prostate size) and side effects 
(e.g. reduced sexual functionality, and multiple non-sexual side effects). Previous studies have shown 
that men prefer medicine that maintains sexual activity in addition to relief of short-term and long-
term symptoms [26, 27]. Preferences were also found to vary between men [27]. We suggest that 
qualitative research can help to better understand why men have different preferences for medical 
treatment of LUTS. 
3 Mixed methods 
3.1 Study overview 
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Our MMA was the first study that combined qualitative data from ODGs with quantitative online DCEs. 
The collected data was used in three ways (Figure 1): First, qualitative analysis of the online discussion 
groups explored how LUTS affects men’s life and men’s attitudes towards medical treatment. Second, 
the ODGs were used to identify the DCE attributes, to frame the choice tasks and to define the ‘no 
treatment’ baseline. Third, the ODG results motivated the DCE analysis, informed the interpretation of 
the estimated trade-offs and provided insights into the overall validity of the quantitative findings. 
[FIGURE 1] 
While literature reviews, validated outcome measures, theoretical arguments and interviews have 
been used to inform the design of DCEs, face-to-face discussion groups have become increasingly 
popular for the identification of attributes and levels [1, 3, 11]. These discussion groups are usually 
recorded, transcribed verbatim and systematically analysed. In contrast, ODGs do not take place in real 
time, instead participants access a purpose build website at any time during a pre-arranged period [28]. 
On this website, ODG participants can read comments of other participants or comment themselves.  
ODGs are increasingly used in qualitative healthcare research [29-31]. Data quality from ODGs are 
found to be comparable to face-to-face discussion groups, but researchers can reach a broader 
population with ODGs [32, 33]. The dedicated website is accessible from home at a time that is suitable 
for participants, which facilitates the inclusion of people who are housebound, have reduced mobility, 
or have busy schedules. ODGs can also be anonymous, which may facilitate the discussion of sensitive 
topics such as incontinence due to LUTS or sexual side effects of medicine [34, 35].  
 
3.2 Data collection 
3.2.1 Online discussion groups 
Five moderated ODGs were conducted over two weeks to understand how LUTS affects men’s QoL; to 
understand men’s experience of, and attitudes towards treatment of LUTS; to develop DCE attributes 
and levels; and to help inform subsequent DCE analysis.  
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Each ODG was ‘live’ for one week, started on Monday morning and was moderated by three 
researchers (SH, DI, VW) identified by their names. At least one moderator was present daily between 
8am and 10pm. A new question was posted every weekday (Table 1). Participants could respond to 
these questions and other participants’ comments. Moderators prompted for information and 
encouraged discussions. The final question was posted on Friday and the website remained open until 
Monday morning. 
[TABLE 1] 
All posted comments were downloaded and analysed independently by the moderators using an 
inductive thematic approach [36, 37]. Each researcher assigned codes that described topics, concerns, 
or emotions in each post on the website. The codes were used to identify overarching themes. The 
three moderators discussed coding strategies and emerging themes in a two-day workshop with the 
objectives: First, to gain insights into the effect of LUTS on men’s QoL as well as attitudes towards 
medical treatment. Second, to identify themes or sub-themes from the qualitative analysis that could 
be included as treatment attributes in the DCE. These themes or sub-themes had to be actionable, 
plausible in the context of treatment choice and tradeable [2]. This means that complex themes may 
require to be broken down into sub-themes (e.g. into different classes of side effects). Other themes 
may not be suitable at all for the inclusion as an attribute in the DCE (e.g. if it is unaffected by treatment 
choice). Third, qualitative insights guided the statistical analysis plan and should inform the 
interpretation of the DCE results at a later stage. For the purpose of the workshop it was agreed in 
advance that disagreements were to be resolved through discussion and if this did not result in 
agreement, by majority vote. No voting was required in this study. As part of the workshop, a 
conceptual map was developed that linked themes and codes to explore interdependencies, by 
comparing which themes were discussed jointly in the ODGs. The purpose of the conceptual map was 
to graphically represent the wider context of the identified themes as well as how the different aspects 
that were raised in the ODGs relate to each other. The conceptual map therefore illustrates the 
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complexity of the disease and treatment context, whereas the DCE reduces this complexity to the key 
attributes. 
3.2.2 Discrete choice experiment 
The DCE quantified the trade-offs that men make when choosing between LUTS treatments in terms of 
their willingness to pay (WTP) for each attribute and explored preference heterogeneity among men. 
Seven attributes were used to describe medical treatments of LUTS (Table 2). Three attributes (day-
time and night-time frequency of urination and day-time urgency) represented symptoms that men 
experience and that medication can potentially improve. Two attributes describe the side effects of 
medications. A cost attribute allowed the estimation of WTP for changes in each attribute and was 
described as ‘all the costs involved in obtaining a prescription and having it dispensed including the 
travel costs such as bus fares, petrol costs, car parking charges, time off work, and any prescription fee’. 
The cost attribute levels were based on previous studies [26, 27]. 
[TABLE 2] 
A D-efficient design with flat priors combined the attributes and levels into 30 choice sets, which were 
split into three blocks of equal size [38]. Each choice set included two hypothetical LUTS treatments 
and an opt-out option. The opt-out was described as a no-treatment option with a day-time frequency 
of 14 times, a night time frequency of 4 times, urge incontinence and no side effects. These relatively 
severe levels were chosen to allow for sufficient variation in symptoms improvement by medicine [42]. 
Figure 2 presents an example choice set.  
[FIGURE 2] 
Attribute levels of the treatment alternatives and the opt-out were chosen such that treatment could 
not worsen LUTS. The opt-out levels were introduced by asking men to imagine that they urinated 14 
times during the day, woke up 4 times to urinate during the night and experienced urge incontinence 
(Figure 2). A link to a description of this baseline scenario was placed above each choice set. 
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The data analysis was based on random utility theory [39] and assumed that utility 𝑢𝑗𝑛𝑡 that respondent 
𝑛 derived from alternative 𝑗 in choice 𝑡 can be split into a deterministic part 𝑣𝑗𝑛𝑡 and a random part 𝜀𝑗𝑛𝑡, 
such that 
𝑢𝑗𝑛𝑡 = 𝑣𝑗𝑛𝑡 + 𝜀𝑗𝑛𝑡 (1) 
The deterministic part of equation (1) was specified as a linear function of the attributes: 
𝑣𝑗𝑛𝑡 = 𝜷𝑛
′ 𝒙𝑗𝑛𝑡 (2) 
with 𝜷𝑛 being an individual specific vector of marginal utilities and 𝒙𝑗𝑛𝑡 denoting the vector of 
attributes. The ODGs suggested that preferences varied between men and marginal utilities were 
therefore assumed to be distributed with a probability distribution 𝑓(𝛽𝑘𝑛|?̅?𝑘, 𝜎𝑘), were ?̅?𝑘 denotes the 
mean and 𝜎𝑘 the standard deviation (SD). The resulting mixed logit was estimated with 3,000 Halton 
draws from 𝑓(𝛽𝑘𝑛|?̅?𝑘 , 𝜎𝑘) [40]. Day-time and night-time frequency were assumed to be log-normal 
distributed to avoid that an implausibly large share of respondents preferred a higher frequency of 
urination. The cost attribute was fixed to ensure that probability distributions of parameter ratios have 
existing moments and the number of tablets was fixed, because no specification resulted in either a 
significant mean or a significant standard deviation. The remaining attributes were normal distributed. 
Mean WTP estimates were obtained as the ratio between the estimated coefficient for an attribute 
and the negative cost coefficient; 95% confidence intervals for WTP estimates were calculated using 
the delta method [41]. All categorical attributes were dummy coded. More details about the model is 
provided in a separate publication [42]. 
3.2.3 Recruitment  
Men residing in the UK, who were registered with a commercially managed online access panel were 
invited to participate in the study, if they were of ≥45 years and had a self-reported International 
Prostate Symptom Score (IPSS) of ≥8. These criteria are associated with increased prevalence of 
storage symptoms [21].  
 11  
Forty-eight eligible men were invited to participate in an ODG and received detailed information. 
Informed consent was obtained and men were asked to provide dates on which they would be 
available. Men registered with a username and password to the website and were identified in the ODG 
only by their username. Users registered to the website were split into groups of 7–10 men with similar 
distributions of age and IPSS. Participants received £30 for contributing at least three comments.  
5,212 men who did not participate in the ODGs were invited to the DCE. Men received information 
about the medical background, the survey structure and completion time. Respondents received £1.50 
for a completed questionnaire. The sampling was paused for one week after 63 respondents had 
completed the questionnaire and this data was used as pilot and has resulted in a minor adjustment of 
the cost attribute based on an unexpected opt-out rate of 33%. Further details on the pilot are 
presented in a separate publication [42]. 
4 Results 
4.1 Online discussion groups 
22 men actively participated in the ODGs. Men had a mean age of 59.82 years and mean IPSS of 16.41. 
223 comments were made across all ODGs (3–22 posts per active participant). 
Seven themes were identified: 1) men’s symptom awareness; 2) experience of day-time frequency and 
urgency; 3) experience of night-time frequency and urgency; 4) determinants and experiences of 
consulting a doctor; 5) attitudes to side effects; 6) psychological well-being; and 7) determinants of self-
care. Figure 3 presents the conceptual map of these themes.  
[FIGURE 3] 
1) Awareness 
All men found their LUTS bothersome, but not all men associated their symptoms to a medical 
condition and some men were unaware that their symptoms were more severe than what is ‘normal’ 
for men their age. For example, Participant 1 in group 5 wrote:  
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“It is […] accepted that as a man when you grow older you are likely to want to use 
the toilet a lot more and is sometimes treated as a bit of a joke, which probably 
contributes to men not paying too much attention to it.” 
Some men had spoken with their general practitioner (GP) and were told that their symptoms were age 
related. Participant 3 in group 4 wrote: 
“I have been to see a doctor […] when I was having to go to the toilet 2 or 3 times 
[at night]. She said it was of no concern and that it is normal for a man my age.” 
2) Day-time symptoms 
Men often discussed the impact of day-time frequency and urgency on their life. Frequently needing 
to urinate was annoying, disruptive, embarrassing and confining to men. For example, Participant 10 in 
group 1, wrote:  
“I would normally only go to places where I know where the toilet is. If it’s a new 
place I have to make sure I go before leaving the house. This can take a while so 
going anywhere always takes longer than it would for others.” 
If men’s careful plans were disrupted, by delays or traffic congestion this was stressful. Participant 9 
from group 2 wrote: 
“Until recently, I had a 3.5 hour drive most Monday mornings and the same on 
Thursday nights. I would anticipate wanting to stop around 1.5 to 2 hours out and 
judge which service station to stop at. Occasionally I misjudge it, or get stuck in 
traffic, and then it becomes uncomfortable. This tends to results in a lot of swearing 
at other road users or traffic lights, if I’m […] getting near my limit.” 
Working men were concerned about how urination frequency affected their work. For example, 
Participant 3 in group 4 wrote:  
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“Recently, it has started to affect my work and I have to go at least four times 
during the shift.”  
Urinary urgency restricts men’s lives and decreases their self-confidence. Several men seldom leave 
home and restrict their social life, because they are afraid of not reaching the toilet on time. For 
example, Participant 8 in group 3 wrote: 
“To minimize accidents I use incontinence pads, which although are a nuisance they 
help me feel more confident if I am going out. This condition wears me down and 
makes me feel like a lesser man.” 
3) Night-time symptoms  
The most frequent response to how LUTS affected men’s life was related to night-time urination 
frequency. Night-time urgency was also mentioned and linked to wetting the bed. For example, 
Participant 6 in group 5 wrote:  
“I am still getting up during the night, it is such a horrible thing. You are fast sleep 
one moment and the next you are awake and trying to get to the toilet as quick as 
possible.” 
Some men reported that their disturbed sleep meant that they were tired during the day. Participant 2 
in group 2 wrote:  
“I often feel tired and sleepy in the afternoons and frequently fall asleep on the sofa 
in the evenings. This means I get very little leisure time as when I finally sit down 
and read a book or watch TV I am too tired and will fall asleep.” 
Men who experienced urgency symptoms at night had experienced incontinence or were worried 
about it. This reduced their confidence, enjoyment of trips away from home and caused worry about 
the effect on their partner whose sleep was disturbed, too. For example, Participant 6 in group 5 said:  
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“[…] I have been as many as four times during the night. […] it is putting a strain on 
my relationship with my wife. […] She is such a light sleeper that I wake her up 
when I am getting in and out of bed. […] We now have separate beds, and also 
sometimes I have been in such a deep sleep that I have accidents during the night, 
and then my wife has to change the bed in the middle of the night. […] My wife 
never says anything she just does it as if it is a part of normal life, but I can tell after 
40 years of being together she does find it all stressful.” 
4) Doctor  
Not all men had consulted their general practitioner (GP). Men gave three main reasons for not 
consulting a GP. First, their symptoms were perceived as not “too bad”. Second, they believed doctors 
could not do anything. Third, they didn’t want to take medication. A minority of men were also scared 
of their symptoms being associated with prostate cancer. In general, LUTS getting “too bad” was not 
an absolute concept, but related to a deterioration in symptoms that substantially decreased QoL. For 
example, Participant 9 in group 2 wrote:  
“I put up with the situation for quite a while and just thought ‘well that’s just the 
way I am’. Also inherited a fear of doctors (they find nasty stuff and maybe I’d 
rather not know). What finally forced the issue was when I started getting urine 
infections and the pain and frequency of needing to go to the toilet and loss of 
control…” 
5) Side effects 
Sexual side effects were perceived as more important than non-sexual side effects for most men. For 
example, Participant 16 in group 2 wrote: 
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“Headaches, dizziness, a dry mouth are not too bad, but I am having enough issues 
with no fluid during ejaculation, inability to get or maintain an erection, decreased 
sexual desire as it is …” 
The importance of sexual side effects to a man depended on his circumstances. Some men were already 
experiencing sexual symptoms. Men who were living alone and were no longer sexually active stated 
that the sexual side effects were irrelevant to them. For example, Participant 5 in group 3 wrote:  
“I am totally impotent, prior to this my GP wanted to prescribe Viagra. As a 
widower of advanced years (72) the impotence does not bother me, so the sexual 
side of my life is one less problem to worry about […].” 
6) Psychological well-being 
LUTS affects men’s psychological well-being. Many worried about going to the toilet when being out, 
about having an accident and about staying overnight away from home. Men felt guilty about how their 
symptoms affected their family or felt trapped at home, because they were afraid of not finding a toilet. 
For example, Participant 6 in group 5 who experienced severe storage symptoms wrote:  
“I am unable to just nip into town as the only public toilet that was there has been 
closed. […] This is a terrible strain on my relationship with my wife, although she 
fully understands and is very comforting to me when I get upset, because I feel like 
a prisoner in my own home at times, because of this problem.” 
7) Self-care 
Men had different strategies to self-care or manage their LUTS. They were conscious of, and sometimes 
limited, their fluid intake. Not all men believed that this worked. Other men wrote about trying to hold 
on and not to “give in” to the urge to urinate. For example, Participant 1 in group 5 wrote:  
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“[I am] [g]enerally more conscious about how much I drink during the day, mainly 
tea, especially with regard to what I will do in the following hours, e.g., long drive. 
Usually do not drink anything after about 6pm or I will almost certainly have to get 
up in the night.” 
The ODGs showed that LUTS reduce men’s QoL and that men organise their day to manage the 
symptoms. Many men were not aware that LUTS is treatable by medicine and many had not contacted 
their GP. This supports our use of online recruitment from the general population using symptom score 
as an inclusion criteria.  In doing so we have included a wider group of men that would have been 
reached by patient groups.  
The ODG informed our attributes. We include day-time and night time frequency of urination and 
urgency as attributes, because these were symptoms most frequently discussed and those that 
potentially can be improved with treatment. The attribute and levels echo the ways in which men 
discussed frequency and urgency in the ODGs. We expected men to value reduced day-time urination 
frequency, because they can take part in more daily activities, and to value reduced night-time 
frequency, because they would have better sleep quality. We included a broad range of side effects. 
In the ODGs, men’s circumstances affected their willingness to take medication with side effects. Men 
who were sexually inactive were less concerned about sexual side effects of treatment, therefore we 
expected to find significant preference heterogeneity for side effects in the DCE results. The range of 
experiences and symptoms reported in ODG meant that we chose to define a baseline situation in the 
DCE to ensure that the DCE made sense to all respondents.  
4.2 Discrete choice experiment 
1,097 men opened the online survey, of which 450 were screened out. 136 men met the eligibility 
criteria, but were over the sampling quota of 310 respondents. 201 men dropped out before 
completing all the questions and 63 were used as pilot study. The final survey was completed by 247 
men, resulting in 7,410 observations for the DCE analysis. Men had a mean age of 62.32 years and a 
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mean IPSS of 15.69. In the sample, 112 men had discussed LUTS with their GP, and 65 (58.04%) of these 
men had received medical treatment.  
Figure 4 presents the mean WTP estimates based on the mixed logit model results. A full set of 
estimates is reported by Mankowski et al. [42]. WTP estimates show how much men are willing to pay 
per month for marginal change in each of the significant attributes (p-value < 0.05). The DCE showed 
that men value medicine, especially if it reduces urinary urgency. However, men’s valuation is reduced 
by side effects, especially sexual side effects. Three coefficients were insignificant (estimate, p-value): 
the reduction in urgency from incontinence to severe urgency, the side effect of dry mouth, and 
number of tablets per day. While it is surprising that a change from urge incontinence to severe urgency 
is not significantly valued by men, one explanation may be that even under severe urgency, men are 
still afraid of wetting themselves while rushing to the toilet. It may be this fear together with the 
requirement of rushing to toilets that prevents the change in urgency to be valued by men. Men may 
also be affected by past experience of incontinence. For example, participant 231 in ODG 1 stated: 
“Several years ago I did wet the bed and this sometimes makes me a little apprehensive  
when we are away.” 
Men were willing to pay more to improve urination urgency than to reduce urination frequency. 
Reducing urgency from incontinence to mild urgency was valued at £25.33 per month, and from 
incontinence to moderate urgency was valued at £23.93 per month. Men were willing to pay more for 
a one-time reduction in night-time frequency than day-time frequency of urination (£6.65 per month 
and £1.39 per month, respectively).  
[FIGURE 4] 
Erectile dysfunction was the worst side effect and reduced the value of medication by £30.07 per 
month. The remaining sexual side effects (no fluid during ejaculation and decreased sexual desire) and 
non-sexual side effects (headache and dizziness) reduced the value of medication by similar values 
(between £16.26 and £19.66 per month).  
 18  
Preferences were found to be heterogeneously distributed in the population for both frequency 
attributes, all levels of the urgency attribute except for an improvement to mild urgency, all levels of 
the sexual side effects attribute except no fluid during ejaculation and all levels of the non-sexual side 
effect attribute except dry mouth. In line with our expectations, we find significant preference 
heterogeneity for the ‘decreased sexual desire’ and ‘impotence levels’ of the sexual side effects 
attribute (Figure 5). More details on estimated SDs are provided in [42].  
[FIGURE 5] 
5 Discussion 
This paper has presented one of the first MMAs in the health literature that combines a DCE with 
qualitative research [11]. Previous studies have mostly published qualitative findings and DCE results 
separately [44-47] or conducted an MMA using non-economic quantitative techniques, such as rating 
or ranking [50]. Current DCE guidelines recommend the use of qualitative research at the study design 
stage. Our findings suggest that qualitative research can complement DCEs at the analysis and 
interpretation stage as well. Qualitative research can provide insights into patients’ preferences and 
attitudes that cannot be obtained by a DCE. For example, the inclusion of random parameters in our 
statistical analysis of the DCE data allowed us to control for preference uncertainty [19], but it did not 
explain these idiosyncratic differences between respondents in terms of differences in personal 
circumstances, tastes and expectations. Qualitative research can also provide insights into causes of 
relative attribute importance. In our DCE, we found that reducing night time frequency was more 
important than day-time frequency. The ODGs suggested that this is because night-time frequency 
disturbs patients’ sleep as well as the sleep of their partners. Therefore, WTP for improving night-time 
frequency in the DCE includes the value of improved sleep for men and their family. Other aspects of 
patients’ treatment choice may simply not be picked up by a DCE. For example, a key finding of our 
qualitative analysis was that men were often unaware of LUTS being treatable and therefore had not 
talked about their symptoms with their doctor or family.  
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While our findings suggest that a MMA would enhance most, if not all DCEs, some issues remain to be 
resolved. Reporting guidelines for DCEs and qualitative research have become complex and require 
the provision of several method-specific study details [51-53]. Fulfilling all of these recommendations 
may not be possible in one journal publication. The high interdependency between qualitative 
research and DCEs also results in an unclear and potentially unnatural presentation ordering. While 
the DCE attributes are results of the qualitative research, they are not the only qualitative research 
output. This may suggest that all qualitative research should be presented before the DCE is discussed. 
However, such a reporting structure would reduce researchers’ ability to discuss and compare 
qualitative evidence together as a common picture that emerges from studying treatment preferences 
in an MMA. We therefore advocate a more interwoven reporting approach. To make such an approach 
more practical and transparent, future discussions about reporting standards of MMAs are needed. 
Our study was also the first to combine an online DCE with ODGs. ODGs may offer a practical and less 
costly alternative to face to face interviews or focus groups. When ODG are undertaken alongside 
online quantitative surveys then ODGs allow researchers to sample all study participants from the 
same population. ODG also enable people with limited mobility to participate in the study. 
Furthermore, we found that using an anonymous username as an identifier helped in the discussion 
of sensitive topics. One participant in discussion group 3 for example stated: 
“As you are only a username and not a physical being it is easier to express your feelings as you are not 
watched and are unaccountable. It gives you more freedom and lifts the 'taboo' barrier.” 
There are some disadvantages of ODGs over face to face discussion groups. The asynchronous nature 
of ODGs reduces the amount of interaction between participants and moderators are less likely to be 
able to engage all participants in discussions. However, these issues may be reduced by providing a 
participation based incentive (e.g. a minimum number of postings). Furthermore, little is known about 
how the anonymity affects the validity of participants’ responses. Future studies should therefore build 
on this study by exploring the ODGs in a different health context by comparing ODGs with face to face 
qualitative methods.  
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Our study contributes to a broad range of different literatures. First, the DCE adds to the limited 
evidence of patients’ preferences for medical treatment of LUTS associated with BPH. Previous studies 
have mainly focussed on men’s preferences for treating BPH (e.g. by decreasing the size of the prostate) 
[26,27]. In contrast, our study focusses on how men experience LUTS and how this experience changes 
due to medical treatment.  Second, our qualitative research extends the findings from other studies 
that show LUTS can have a severe effect on the QOL of men and their partners [22-24]. Third, our 
discussion of combining and reporting DCEs together with qualitative research in a MMA builds on and 
extends previous work that explores how qualitative research can inform the design of DCEs 
[3,10,11,54-63].   
Our analysis is subject to some limitations: 1) The ODGs suggested that some of the preference 
heterogeneity around the sexual side-effects attribute is caused by the degree to which men are 
sexually active. We did not collect such data in the DCE questionnaire and could therefore not account 
for sexual activity in our analysis. However, sexual activity is only one of several reasons for preference 
heterogeneity in the valuation of the sexual side effects attribute. This is why we assumed parameters 
to be randomly distributed in the population. 2) As noted by Mankowski et al. [42], our results may 
not be representative for all patients suffering from LUTS due to BPH. Using the online access panel, 
we achieved an estimated recruitment rate of 14.58%, but have no information about how responders 
differed from non-responders or UK population that is not signed up to the panel. 3) Our DCE assumes 
that taking no medicine results in a fixed set of symptoms and does not allow for any changes in LUTS 
due to progression of BPH. We have chosen to fix the opt-out alternative to a defined scenario to make 
choices comparable and to avoid instances in which taking medicine resulted in worse scenarios than 
taking no medicine. 4) Our sampling criteria relies on self-reported IPSS, which is not equivalent to a 
clear medical diagnosis and as a result, men may be suffering from other diseases such as urinary tract 
infections or prostatic cancer. Using self-reports also allowed us to explore men’s disease awareness 
in the ODGs, which is in line with studies that find low consultation rates for men suffering from LUTS 
[43]. 5) the DCE only considered storage symptoms of LUTS, because these symptoms were found to 
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be the most bothersome to men in the ODGs. However, this is in line with findings from other studies 
in the literature [64, 65]. 
6 Conclusion 
This paper went beyond the recommendations of DCE guidelines by showing how qualitative methods 
can complement a DCE. Our MMA informed the DCE attributes and levels, provided behavioural 
insights on its own and informed the interpretation of DCE parameter estimates. As a result, the MMA 
provided more detailed insights into patients’ preferences than qualitative or quantitative research 
could have provided alone.  
References 
1. Clark MD, Determann D, Petrou S, et al. Discrete Choice Experiments in Health Economics: A 
review of the Literature. PharmacoEconomics. 2014;32:883–902. 
2. Ryan M. A role for conjoint analysis in technology assessment in health care? Int J Technol 
Assess Health Care. 1999;15:443–57. 
3. Coast J, Al-Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for 
discrete choice experiments: issues and recommendations. Health Econ. 2012;21:730–41. 
4. Ryan M, Wordsworth S. Sensitivity of Willingness to Pay Estimates to the Level of Attributes in 
Discrete Choice Experiments. Scottish Journal of Political Economy 2000;47(5):504–524.  
5. Ratcliff J, Longworth L. Investigating the structural reliability of a discrete choice experiment 
within health technology assessment. International Journal of Health Technology Assessment 
in Health Care, 2002;18:139–144. 
6. Louviere JJ. Choice experiments: an overview of concepts and issues. In: The Choice Modelling 
Approach to Environmental Valuation. Bennett J, Blamey R (eds.). 2001, Edward Elgar: 
Northhampton. 13–36.  
7. Viney R, Savage E, Louviere JJ. Empirical investigation of experimental design properties of 
discrete choice experiments in health care. Health Econ. 2005;14(4):349–362.  
 22  
8. Witt J, Scott A, Osborne RH. Designing choice experiments with many attributes. An 
application to setting priorities for orthopaedic waiting lists. Health Econ. 2009;18:681–96. 
9. Fernández-Antolína A, Guevara-Cueb A, de Lapparenta M, Bierlairea M. Correcting for 
endogeneity due to omitted attitudes: Empirical assessment of a modified MIS method using 
RP mode choice data. Journal of Choice Modelling 2016; 20: 1–15 
10. Kløjgaard ME, Bech M, Søgaard P. Designing a Stated Choice Experiment: The Value of a 
Qualitative Process. Journal of Choice Modelling; 2012;5(2):1–18.  
11. Vass C, Rigby D, Payne K. The Role of Qualitative Research Methods in Discrete Choice 
Experiments: A Systematic Review and Survey of Authors, Medical Decision Making. 
2017;DOI: 10.1177/0272989X16683934 
12. Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: 
current practice and future research reflections. Appl Health Econ Health Policy. 2003;2:55–
64. 
13. de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a 
review of the literature. Health Econ 2012;21(2):145–172. 
14. Morse JM. Approaches to qualitative-quantitative methodological triangulation. Nurs Res. 
1991;40(4):120–123. 
15. Boulton M, Fitzpatrick R. Qualitative methods for assessing health care. Quality in Health 
Care. 1994;3(2):107-113. 
16. Harding G, Gantley M. Qualitative Research: Beyond the cookbook. 1998;15:76-79. 
17. Baum F. Researching public health: behind the qualitative-quantitative debate. Social Science 
& Medicine. 1995;40(4):459–468. 
18. Obermann K, Scheppe J and Glanzinski B. ‘More than figures? Qualitative research in health 
economics. Health Economics. 2013; 22:253-257.  
19. Hensher DA, Greene WH. The Mixed Logit model: The state of practice. 2003;30(2):133-176. 
20. Issa MM, Regan TS. Medical therapy for benign prostatic hyperplasia-present and future 
impact. Am J Manag Care. 2007;13(Suppl 1):S4–9. 
 23  
21. National Institute for Health and Clinical Excellence (NICE) clinical guidelines: CG97. Lower 
urinary tract symptoms: The management of lower urinary tract symptoms in men (Issued: 
June 2010). Available from: http://www.nice.org.uk/nicemedia/live/12984/48557/48557.pdf. 
Accessed 1 December 2014. 
22. Sells H, Donovan J, Ewings P, et al. The development and validation of a quality-of-life 
measure to assess partner morbidity in benign prostatic enlargement. BJU Int. 2000;85:440–
5. 
23. Bertaccini A, Vassallo F, Martino F, et al. Symptoms, bothersomeness and quality of life in 
patients with LUTS suggestive of BPH. Eur Urol. 2001;40(Suppl 1):13–8. 
24. Batista-Miranda JE, Molinuevo B, et al. Impact of lower urinary tract symptoms on quality of 
life using Functional Assessment Cancer Therapy scale. Urology. 2007;69:285–8. 
25. Speakman MJ. Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia 
(LUTS/BPH): More Than Treating Symptoms? European Urology Supplements. 2008;7:680–
689 
26. Watson V, Ryan M, Brown CT, et al. Eliciting preferences for drug treatment of lower urinary 
tract symptoms associated with benign prostatic hyperplasia. J Urol. 2004;172:2321–5.  
27. Eberth B, Watson V, Ryan M, et al. Does one size fit all? Investigating heterogeneity in men's 
preferences for benign prostatic hyperplasia treatment using mixed logit analysis. Med Decis 
Making. 2009;29:707–15. 
28. Tates K, Zwaanswijk M, Otten R, et al. Online focus groups as a tool to collect data in hard-to-
include populations: examples from paediatric oncology. BMC Med Res Methodol. 2009;9:15. 
29. Stewart K, Williams M. 2005. Researching online populations: the use of online focus groups 
for social research. Qualitative Research. 2005;5:395–416. 
30. O’Connor H and Madge C. ‘Focus Groups in Cyberspace’: Using the Internet for Qualitative 
Research, Qualitative Market Research: An International Journal. 2003:133–143. 
 24  
31. Eysenbach G, Wyatt J. Using the Internet for surveys and health research. J Med Internet Res. 
2002;4:E13.Fitzgerald MP, Brubaker L. Variability of 24-hour voiding diary variables among 
asymptomatic women. J Urol 2003:169:207–9. 
32. Reid FJM, Reid DJ. Online focus groups: an in-depth comparison of computer-mediated and 
conventional focus group discussions Int J Market Res. 2005;47:131–62. 
33. Koch NS, Emrey JA. 2001. The Internet and Opinion Measurement: Surveying Marginalized 
Populations, Social Science Quarterly. 2001;82:131–138. 
34. Caplan SE, Turner JS. Brining theory to research on computer-mediated comforting 
communication. Computers in Human Behaviour 2007;23:985–998. 
35. Tidwell LC, Walther JB. Computer-mediated communication effects on disclosure, 
impressions, and interpersonal evaluations. Getting to know one another a bit a time. Hum 
Communicat Res. 2002;28:317–48. 
36. Coffey A, Atkinson, P. Making sense of qualitative data. Sage Publications: London and New 
Delhi, 1996. 
37. Boyatzis R. Thematic analysis and code development: transforming qualitative information. 
Thousand Oaks, CA, USSage Publications: London and New Delhi, 1998. 
38. Kuhfeld WF. Marketing research methods in SAS: experimental design, choice, conjoint and 
graphical techniques. SAS Institute Inc, Cary, NC, USA, 2009. 
39. McFadden, D. Conditional logit analysis of qualitative choice behavior, in Frontiers in 
econometrics, ed. P. Zarembka, Academic Press, New York; 1974. 105–142. 
40. Train K. Discrete choice methods with simulation. New York: Cambridge University Press, 2nd 
edition, 2009. 
41. Oehlert GW. A Note on the delta method. Am Stat 1992;46:27–9. 
42. Mankowski C, Ikenwilo D, Heidenreich S, Ryan M, Nazir J, Newman C, Watson V. Men’s 
preferences for the treatment of lower urinary tract symptoms associated with benign 
prostatic hyperplasia: a discrete choice experiment. Patient preference and adherence. 2016; 
2016(10):2407-2417.  
 25  
43. Hunter DJ, Berra-Unamuno A. Treatment-seeking behaviour and stated preferences for 
prostatectomy in Spanish men with lower urinary tract symptoms. Br J Urol. 1997;79:742–8. 
44. Llewellyn C, Pollard A, Miners A, et al. Understanding patient choices for attending sexually 
transmitted infection testing services: a qualitative study. Sex Transm Infect. 2012;88(7):504–
509. 
45. Miners A, Llewellyn C, Pollard A, et al. Assessing user preferences for sexually transmitted 
infection testing services: a discrete choice experiment. Sex Transm Infect. 2012;88(7):510–
516. 
46. Hiligsmann M, van Durme C, Geusens P, et al. Nominal group technique to select attributes 
for discrete choice experiments: an example for drug treatment choice in osteoporosis. 
Patient Preference and Adherence. 2013;7:133–139. 
47. Hiligsmann M, Delleart BGC, Dirksen CD, et al. Patients’ preferences for osteoporosis drug 
treatment: a discrete choice experiment. Arthritis Research & Therapy. 2014; 16:R36. 
48. Abiiro GA, Leppert G, Mbera GB et al. Developing attributes and attribute-levels for a discrete 
choice experiment on micro health insurance in rural Malawi. BMC Health Services Research. 
2014a;14:235. 
49. Abiiro GA, Torbica A, Kwalamasa K, et al. Eliciting community preferences for complementary 
micro health insurance: A discrete choice experiment in rural Malawi. Social Science & 
Medicine. 2014b;120:160–168. 
50. Eiring Ø, Nylenna M, Nytrøen K. Patient-Important Outcomes in the Long-Term Treatment of 
Bipolar Disorder: A Mixed-Methods Approach Investigating Relative Preferences and a 
Proposed Taxonomy. The Patient. 2016; 9(2): 91-102. 
51. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): 
a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-
357. 
52. O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards of reporting qualitative 
research: a synthesis of recommendations. Academic Medicine. 2014;89(9):1245-1251. 
 26  
53. Lancsar E, Louviere JJ. Conducting Discrete Choice Experiments to Inform Healthcare Decision 
Making: a user’s guide. PharmacoEconomics. 2008;26(8):661-677. 
54. Coast J, Horrocks SA. Developing attributes and levels for discrete choice experiments using 
qualitative methods. Journal of Health Service Research & Policy. 2007;12:25-30. 
55. Janssen EM, Segal JB, Bridges JF. A Framework for Instrument Development of a Discrete 
Choice Experiment: An Application to Type 2 Diabetes. 2016;9(5):465-479. 
56. Wittenberg E, Bharel M, Saada A, Santiago E, Bridges JF, Weinreb L. Measuring Preferences of 
Homeless Women for Cervical Cancer Screening Interventions: Development of a Best-Worst 
Scaling Survey. The Patient. 2015;8(5):455-467. 
57. McCaffrey N, Gill L, Kaambwa B, et al. Important features of home-based support services for 
older Australians and their informal carers. Health & Social Care in the Community. 
2015;23(6): 654–664. 
58. Kaambwa B, Lancsar E, McCaffrey N, et al. Investigating consumers’ and informal carers’ 
views and preferences for consumer directed care: A discrete choice experiment. Social 
Science & Medicine. 2015;140:81–94. 
59. Gallego G, Dew A, Bulkeley K, et al. Factors affecting retention of allied health professionals 
working with people with disability in rural New South Wales, Australia: discrete choice 
experiment questionnaire development. Human Resource for Health. 2015a;13:22. 
60. Gallego G, Dew A, Lincoln M, et al. Should I stay or should I go? Exploring job preferences of 
allied health professionals working with people with disability in rural Australia. Human 
Resource for Health. 2015b;13:53. 
61. Tobiano G, Bucknall T, Marshall A, Guinane J, Chaboyer W. Nurses' views of patient 
participation in nursing care. J Adv Nurs. 2015;71:2741–52. 
62. Tobiano G, Bucknall T, Marshall A, Guinane J, Chaboyer W. Patients' perceptions of 
participation in nursing care on medical wards. Scand J Caring Sci. 2016;30:260–70.  
 27  
63. Spinks J, Chaboyer W, Bucknall T, Tobiano G, Whitty JA. Patient and nurse preferences for 
nurse handover-using preferences to inform policy: a discrete choice experiment protocol. 
BMJ Open. 2015;5:e008941. 
64. Peters TJ, Donovan JL, Kay HE, et al. The International Continence Society “benign prostatic 
hyperplasia” study: the botherosomeness of urinary symptoms. J Urol. 1997;157(3):885–889. 
65. Abrams P, Manson J, Kirby M. Incidence and epidemiology of storage lower urinary tract 
symptoms. Eur Urol Rev. 2012;7:50–54. 
  
 28  
Figure 1 Flow chart of the mixed method study  
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Figure 2 Example choice set 
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Figure 3 Conceptual map illustrating interdependencies between themes, codes and topics a 
 
a Themes are represented by boxes, arrows connect sub-themes to themes and indicate relationships between 
themes, and orange dotted lines represent complex relationships between sets of themes.  
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Figure 4 Men’s mean willingness to pay for each attribute a,b,c,d  
 
*, p<0.005; **, p<0.001 
a WTP estimates show the value that men put on each attribute (and level) of medication. For urinary frequency, the 
estimates are for a reduction in frequency of 1 time. For urinary urgency, the estimates are for a change from urge 
incontinence to the specified level of urgency. For side effects, the estimates are for the occurrence of the stated side effect 
versus no side effect. Bars above the horizontal axis denote attributes that have a positive effect on utility and men are 
willing to pay for that attribute. Bars below the horizontal axis denote attributes that have a negative effect on utility and 
men are willing to pay to avoid that attribute. 
b Error bars denote 95% confidence intervals.3 
c insignificant WTP estimates are excluded from the graph: Constant = -£6.53 [-£16.73; £3.68], Severe urgency = -£1.93 , Dry 
mouth = -£2.85 [-£9.14;£3.44], Number of tablets = £1.43 [-£2.10; £4.96] 
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Figure 5 The distribution of WTP for sexual side-effects in the DCE sample a,b 
 
 
a Distributions are based on the conditional parameter distribution of the sample [5,19] 
b The negative WTP means that men’s valuation decreases if a medicine has side effects 
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Table 1 Online discussion groups: questions posed by moderators 
Welcome (Day 1) 
Welcome to this online bulletin board about the treatment of urinary symptoms. Your answers to the 
short questionnaire last week indicate that you experience symptoms such as: 
- A frequent need to go to the toilet, day or night 
- The feeling of delay or hesitation when you start to urinate 
- The feeling that you cannot empty your bladder completely 
- The feeling that you must urinate right away 
We would like to understand: 
- How these symptoms affect your day-to-day life 
- If you receive treatment 
- What men like you think about different aspects of the available treatments for these symptoms. 
To help us understand, each day we will ask you a question. We are interested in your answers to 
these questions and the answers of the group. You might find other people’s answers interesting and/or 
different from your own. Throughout there are no right or wrong answers, we are interested in your 
opinion. Thank you very much for agreeing to take part and sharing your opinion with us. 
 
Urinary symptoms and your day-to-day life (Day 1) 
In the short questionnaire last week, you indicated that you experience symptoms such as: 
- A frequent need to go to the toilet, day or night 
- The feeling of delay or hesitation when you start to urinate 
- The feeling that you cannot empty your bladder completely 
- The feeling that you must urinate right away 
Can you tell us how these symptoms affect your day-to-day life? 
Managing your symptoms (Day 2) 
Thank you for all your comments on Monday. They were really useful to help us understand how your 
symptoms affect your life. Today, we would like to understand how you manage your symptoms. Do you 
take any medicine to help manage your symptoms? If you take medicine, are you satisfied with the effect 
this has on your symptoms? If you don’t take medicine, could you tell us why? (There are no right or wrong 
answers, we are interested in your opinion). Thanks again for all your help. 
Medicine side effects (Day 3) 
Yesterday we were discussing medicines. Some people take medication and they said it can help with 
their symptoms. Other people don't take medication for several reasons. Today we would like to discuss 
the different side effects that medicines might have. Different medicines have different side effects. But 
the most frequently reported side effects of medicine to treat urinary symptoms are: 
- Headaches 
- Dizziness 
- A dry mouth 
- No fluid during ejaculation (dry orgasm) 
- Inability to get or maintain an erection 
- Decreased sexual desire 
Would/have these side effects put you off taking medicine? How do you weigh up the possible benefits of 
treatment against the possible side effects? Thanks for all your comments so far they are really helpful. Best 
wishes. 
Consulting a doctor (Day 4) 
From your answers, we understand there is mix of people on the bulletin board. Some of you are taking 
medication and others are not. Those of you not taking medication have told us that you might consider 
taking medication if your symptoms got worse. Today, we would like to understand what would make you 
visit the doctor and discuss medication in the future? If you are taking medication – what made you visit the 
doctor to discuss your symptoms? Thank you for all your help. Best wishes. 
Final comments (Day 5) 
Today is the last day on which we will post a new topic to the bulletin board. The bulletin board will close 
on Monday morning. We have found all of your thoughtful responses and comments very helpful, and we 
would like to thank you very much for taking the time to contribute. Today we would like to ask you questions 
about the bulletin boards this week: Have you been surprised by the topics that we have discussed? Did we 
miss something that you expected to come up? Overall, how have you found the experience of taking part 
in the bulletin board this week? Many thanks and best wishes. 
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Table 2 Attributes of the discrete choice experiment 
Attributes Levels 
Day-time frequency 8, 10, 12, 14 times 
Night-time frequency 1, 2, 3, 4, times 
Day-time urgency Mild  
can postpone as long as necessary, without fear of wetting yourself 
Moderate  
can postpone temporarily, without fear of wetting yourself 
Severe  
cannot postpone and have to rush to the toilet in order not to wet yourself 
Urge incontinence  
have to rush to the toilet and leak before you get there 
Sexual side effects No fluid during ejaculation 
Decreased sexual desire 
Impotence 
Non-sexual side effects Dry mouth 
Headache 
Dizziness 
Number of tablets per day 1, 2 
Cost of treatment (monthly) £5, £10, £20 and £40 
 
